Patents by Inventor Edward Kevin HRUSOVSKY

Edward Kevin HRUSOVSKY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUANTIFICATION OF NEUROFILAMENT LIGHT CHAIN IN PHYSIOLOGICAL SAMPLES
    Publication number: 20220229073
    Abstract: The present disclosure relates to immunoassays for NF-L performed on liquid samples derived from physiological fluids such as venous blood to detect the presence or absence of a physiological condition by quantifying one or a combination of NF-L determinations at concentrations indicative of the condition.
    Type: Application
    Filed: April 9, 2019
    Publication date: July 21, 2022
    Applicant: QUANTERIX CORPORATION
    Inventors: Edward Kevin HRUSOVSKY, David WILSON, Dandan SHAN, Lei CHANG, Linan SONG, Andreas JEROMIN, Carmen Ioana TOBOS, Purvish Prahlad PATEL
  • QUANTIFICATION OF BIOMARKERS PRESENT IN PHYSIOLOGICAL SAMPLES
    Publication number: 20210102959
    Abstract: The present disclosure relates to immunoassays for NF-L, GFAP, UCH L1, and Tau performed on liquid samples derived from physiological fluids such as venous blood to detect the presence or absence of a physiological condition by quantifying one or a combination of NF-L, GFAP, UCH L1, and Tau at concentrations indicative of the condition.
    Type: Application
    Filed: April 9, 2019
    Publication date: April 8, 2021
    Applicant: QUANTERIX CORPORATION
    Inventors: Edward Kevin HRUSOVSKY, David WILSON, Dandan SHAN, Lei CHANG, Linan SONG, Andreas JEROMIN, Carmen Ioana TOBOS, Purvish Prahlad PATEL
  • QUANTIFICATION OF BIOMARKERS PRESENT IN DRIED PHYSIOLOGICAL SAMPLES
    Publication number: 20210096140
    Abstract: The present disclosure relates to digital immunoassays performed on diluted samples obtained from dried blood spots, for example dried capillary blood samples, to detect the presence or absence of a physiological condition by quantifying one or a combination of biomarkers at concentrations indicative of the condition.
    Type: Application
    Filed: April 9, 2019
    Publication date: April 1, 2021
    Applicant: QUANTERIX CORPORATION
    Inventors: Edward Kevin HRUSOVSKY, David WILSON, Dandan SHAN, Lei CHANG, Linan SONG, Andreas JEROMIN, Carmen Ioana TOBOS, Purvish Prahlad PATEL